|

|

Angela M. Furlanetto, Partner

Since being called to the Ontario Bar in 1998, Angela's practice has focussed on all areas of intellectual property litigation with an emphasis on patent litigation, particularly in the pharmaceutical, chemical and biotech fields, including matters relating to the Patented Medicines (Notice of Compliance) Regulations. Angela is both a registered patent and trademark agent.

Angela has significant experience in all aspects of intellectual property litigation, ranging from pre-litigation opinions to conduct of matters through trial and appeal. She has worked with counsel in various jurisdictions to co-ordinate the Canadian part of multi-jurisdictional lawsuits.

Angela is a regular speaker at conferences and a frequent contributor to intellectual property publications. She is a member of the American Intellectual Property Law Association, and Co-Chair of the Harold G. Fox Moot on intellectual property law. Angela is also active in committees on intellectual property litigation: as a Fellow of the Intellectual Property Institute of Canada (IPIC), she is past Chair of the IPIC Litigation Committee; the current Chair of the IPIC Intervention Committee; Vice-Chair of the Canadian Bar Association’s (CBA) National IP Section and a member of the CBA’s Court Practice Committee. Angela is also one of a select few IP litigators who have served on the Federal Court IP Users' Committee, a Committee acting as liaison between judiciary and the IP Bar.  Angela is described as "a fine litigator with an exceptionally active practice" and has been ranked "Bronze" in litigation by IAM Patent 1000 (2012).  She has been named to the International Who's Who of Life Sciences Lawyers for 2013 and was ranked by Benchmark Canada as a Future Star - Ontario (2013).

Prior to earning her LL.B. from the University of Western Ontario in 1996, Angela obtained a M.Sc. in Biochemistry from the University of Western Ontario in 1993 and a B.Sc. in Biochemistry (Summa cum laude) from McMaster University in 1991.

 

Selected presentations and publications:

Presentations

"Canadian Duty of Good Faith vs. the U.S.:  Where the Law is Headed (Generic Perspective)", 9th Edition Drug Patents in Canada, Toronto, May 2010 

"Written Advocacy in the Federal Court:  Tips, Traps and Techniques - Actions involving intellectual property", Osgoode Hall Law School York University, Toronto, April 2010

Advisory Board member and scheduled presenter, 8th Drug Patents and Legal Forum, Toronto, May 2009

"Selection patents (generic perspective)" Insight Drug Patents Conference, Toronto, February 2008

"Patent timelines - maximizing possibilities from innovator and generic perspectives" Canadian Institute 7th Annual Pharma Patents Summit, Toronto, October 2007

"Advising the Canadian client about U.S. law" NYSBA/IPIC, Ithaca, New York, August 2007

"Patent listing issues under the PM (NOC) Regulations" Canadian Institute 6th Annual Pharma Patents Summit, Toronto, October 2006

"The burden of proof in PM (NOC) proceedings" Insight Drug Patents Conference, Toronto, February 2006

Publications

"Supreme Court weighs in on the authority of the patented medicine prices review board", CBA Business and Corporate e-newsletter, February 2011 (co-author)

"Big pharma wins again", The Lawyers Weekly, Sept. 2009 (co-author)

"MedImmune v. Genentech: has the U.S. Supreme Court upset the bargain between patent holders and their licensees" The Lawyers Weekly, April 2007

"U.S. cases on ‘patent trolls’ will address important issues for Canadian IP" The Lawyers Weekly, April 2006 (co-author)

"U.S. Supreme Court helps fight against patent trolls" IP Law Quarterly, Federated Press, 2006 (co-author)

"Review of recent developments in patent law" Guide to Patent Law Experts 2005, Euromoney (co-author)

"Review of proposed changes to the PM(NOC) Regulations" The Lawyers Weekly, 2005 (co-author)